Share Prices & Company Research

Stockbroking

Optibiotix Health

Current Price 47.11p Bid 47.00p Ask 49.00p Change -4.95%
Last Updated: 21/09/2019 10:40. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

OptiBiotix Health plc (formerly Ducat Ventures plc, formerly Ceres Media International plc) was formed in March 2012 to develop compounds which modify the human microbiome - the collective genome of the microbes in the body - to prevent and manage human disease. ). The company brings science to the development of compounds which modify the human microbiome - the collective genome of the microbes in the body - in order to prevent and manage human disease and promote wellness. OptiBiotix has an extensive R&D program working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks. OptiBiotix is also developing its own range of consumer supplements and health products. The Company's current areas of focus include obesity, cardiovascular health, and diabetes.

Financial Highlights Year Ended 30/11/2018

Turnover
£0.51m
Operating Profit
£-1.50m
Dividend Yield
0.00
Dividend Per Share
0.00
Dividend Cover
0.00
P/E Ratio
-21.67

Key Personnel

Stephen Patrick O`Hara
Chief Executive Officer
Dr Sofia Kolyda
Executive Director
Dr Frederic Narbel
Executive Director
Richard Colin Neil Davidson
Non-Executive Chairman
Dr Gareth Allan Barker
Non-Executive Director
Jan Peter Fredik Wennstrom
Non-Executive Director
Michael Sean Christie
Non-Executive Director

Stock Details

EPIC
OPTI
ISIN
GB00BP0RTP38
Shares in Issue
85,440,551
Market cap
£43.15m
Sector

Analyst Views (0)

Strong Buy
 
0.00%
Buy
 
0.00%
Hold
 
0.00%
Sell
 
0.00%
Strong Sell
 
0.00%
The above information represents a selection of the views published in the last 120 days by analysts. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
48.00p
Bid Price
47.00p
Ask Price
49.00p
Volume
281067
Change Today
-2.50p
% Change Today
-4.95%
Open
50.50p
Previous Close
48.00p
Intraday High
53.50p
Intraday Low
47.00p
52 Week High
102.25p
52 Week Low
43.00p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

Optibiotix Health Intra-day Chart

Optibiotix Health News

News in this section is provided by AJ Bell

OptiBiotix Health inks distribution pact for South Africa, neighbouring countries 18 Sep 2019 | 07:48 Director Deals - Optibiotix Health Plc (OPTI) 28 Aug 2019 | 11:05 OptiBiotix Health books first-half loss as it inks more distribution pacts 28 Aug 2019 | 08:01 OptiBiotix Health inks distribution pact in Australia, NZ with Maxum Foods 12 Aug 2019 | 08:01 OptiBiotix Health inks agreement with BioEnergiser for online distribution of its appetite suppressant 18 Jul 2019 | 08:49 OptiBiotix Health inks license agreement with Tenshindo in Japan 03 Jul 2019 | 07:54 OptiBiotix Health inks licencing agreement with Kappa Bioscience 01 Jul 2019 | 08:51 OptiBiotix Health inks North America supply agreement with Agropur 24 Jun 2019 | 07:13 OptiBiotix Health inks sales pact for Vietnam with Biovagen Healthcare 10 Jun 2019 | 07:52 Director Deals - Optibiotix Health Plc (OPTI) 29 May 2019 | 16:20 OptiBiotix Health appoints Stephen Prescott as CEO of ProBiotix unit 28 May 2019 | 07:39 OptiBiotix Health signs up Extensor as Poland distribution partner 22 May 2019 | 09:14 OptiBiotix Health inks licence agreement with Italy's Nutrilinea 20 May 2019 | 07:36 OptiBiotix Health inks Thailand distribution pact with Primo Trading 14 May 2019 | 07:45 OptiBiotix Health inks licence agreement in Spain 07 May 2019 | 09:38 OptiBiotix Health to launch weight management product in Europe next week 01 May 2019 | 09:20 OptiBiotix Health swings to loss as expenses weigh 29 Apr 2019 | 08:04 OptiBiotix Health launches weight management product in UK 24 Apr 2019 | 07:20 OptiBiotix Health inks distribution pact for Bulgaria 09 Apr 2019 | 07:20 OptiBiotix Health inks distribution pact with Silv Expo for Russia and Kazakhstan 27 Mar 2019 | 07:43 OptiBiotix Health inks distribution pact with DKSH in Italy and Spain 20 Mar 2019 | 07:13 OptiBiotix Health extends supply agreement with HLH BioPharma Vertriebs 15 Mar 2019 | 07:46 OptiBiotix Health presents studies on products at Copenhagen conference 20 Feb 2019 | 08:25 OptiBiotix Health expects revenue boost as it switches from R&D focus 13 Feb 2019 | 07:51 OptiBiotix Health inks Japan distribution agreement with EIWA Trading 11 Feb 2019 | 07:34 OptiBiotix Health inks distribution pact with SilvEXPO for Russia, Kazakhstan 09 Jan 2019 | 07:54 OptiBiotix Health inks India supply pact with Zeon Lifesciences 07 Jan 2019 | 07:13 OptiBiotix Health unit ProBiotix raises capital to fund potential spin off 14 Dec 2018 | 07:27 OptiBiotix Health inks Greece, Cyprus distribution pact 04 Dec 2018 | 09:10 OptiBiotix Health grants exclusive license deal to Nutrilinea for the supply of SlimBiome Medical in Europe 29 Nov 2018 | 07:18

Assets (£m)

Data has been provided by AJ Bell

Reporting Date
30 Nov 2018
30 Nov 2017
Tangible Assets
0.0
0.0
Intangible Assets & Goodwill
2.3
1.9
Investments & Other Non-Current Assets
3.7
4.2
Total Non-Current Assets
6.0
6.1
Inventory
0.0
0.0
Trade & Receivables
0.4
0.1
Cash & Receivables
1.3
1.3
Other Current Assets & Assets Held for Resale
0.3
0.2
Total Assets
8.0
7.7

Liabilities (£m)

Data has been provided by AJ Bell

Reporting Date
30 Nov 2018
30 Nov 2017
Short Term Liabilities
0.5
0.2
Long Term Liabilities
0.5
0.4
Other Liabilities / Pension etc
0.0
0.0
Total Liabilities
1.0
0.6

Net Assets (£m)

Data has been provided by AJ Bell

Reporting Date
30 Nov 2018
30 Nov 2017
Net Assets
7.1
7.1

Equity (£m)

Data has been provided by AJ Bell

Reporting Date
30 Nov 2018
30 Nov 2017
Share Capital
1.7
1.6
Minority Interests
0.0
0.0
Retained Earnings
1.6
-2.8
Share Premium Account
1.6
6.3
Other Equity
2.1
2.0
Total Equity
7.1
7.1

Cashflow (£m)

Data has been provided by AJ Bell

Reporting Date
30 Nov 2018
30 Nov 2017
Cashflow from Operating Activities
-1.2
-1.8
Cashflow Before Financing
-1.7
-2.0
Increase / Decrease in Cash
1.8
-1.9

Income (£m)

Data has been provided by AJ Bell

Reporting Date
30 Nov 2018
30 Nov 2017
Turnover
0.5
0.2
Cost of Sales
0.2
0.1
Gross Profit
0.4
0.1
Operating Profit
-1.5
-2.1
Pre-Tax Profit
-2.0
1.7
Profit / Loss for the Year
-1.9
1.9
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.